Clinical trial
Irbesartan and Atenolol in Hypertensive Heart Disease
NCT00389168 · Karolinska Institutet, Other · Completed
Key facts
| NCT number | NCT00389168 |
|---|---|
| Title | Irbesartan and Atenolol in Hypertensive Heart Disease |
| Official title | Randomized, Double-blind Evaluation of the Effects of Irbesartan and Atenolol on Cardiovascular Structure and Function in Subjects With Hypertension and Left Ventricular Hypertrophy |
| Acronym | SILVHIA |
| Lead sponsor | Karolinska Institutet, Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi Swedish Heart Lung Foundation |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Irbesartan, Atenolol |
| Enrollment | 115 |
| Start date | Apr 1, 1995 |
| Primary completion | Apr 1, 1997 |
| Completion | Apr 1, 1997 |
| First posted | Oct 18, 2006 |
| Last update posted | May 5, 2015 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: